Skip to content

Predicting malignancy in thyroid AUS: ultrasonographic and clinical risk factors beyond ACR TI-RADS.

Oct 2026 · European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 0 citations · 21 references
Medicine

TL;DR

The ACR TI-RADS was significantly associated with malignancy in both the overall AUS cohort and the nuclear atypia subgroup, and the relatively high number of follicular thyroid carcinoma cases may have masked the predictive value of ultrasonography.

View source

Similar papers

Review Open access Oct 2026

Diagnostic Performance and Radiocytological Correlation of ACR TI-RADS in Thyroid Nodules Using Bethesda-Reported FNAC as the Reference Standard

OBJECTIVES This study aimed to evaluate the diagnostic performance and radiocytological concordance of American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) categories for thyroid nodules, using fine-needle aspiration cytology (FNAC) reported according to the Bethesda System as the refer...

Shanza Khan, Maimoona Afsar, Ashfa Ameer Khan et al. · 0 citations
Review Open access Oct 2026

Preoperative Ultrasonographic Characteristics and Diagnostic Utility of Cytological Findings in Non-invasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features: Single Center Experience

Objective: Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is a low-risk thyroid malignancy. The aim of this study was to observe the preoperative diagnostic characteristics of NIFTP nodules.Methods: Data from a total of 38 patients aged >18 years, diagnosed postoperatively with hi...

D. Geneş, Zafer Pekkolay, Mustafa Nacir et al. · 0 citations
Open access Sep 2026

Preoperative Malignancy Risk Stratification in Bethesda IV Thyroid Nodules Using Integrated Clinical, Ultrasonographic, and Biochemical Parameters in Surgical Oncology Practice

Background and Objectives: Bethesda Category IV thyroid nodules present a diagnostic challenge due to their variable risk of malignancy and uncertain cytological features. Therefore, determining the risk of malignancy before surgery is important. This study aims to identify clinical, biochemical, and ultrasonographic f...

Y. Kahraman, İsmail Özer, M. Aydın et al. · 0 citations
Open access Aug 2026

Comparison of ACR TI-RADS and ATA Ultrasound Risk Stratification for Thyroid Nodules – Data from a Tertiary Hospital in the United Arab Emirates

Abstract Objective Accurate thyroid nodule risk stratification is critical to guide biopsy decisions and minimize unnecessary procedures. This study compared the diagnostic performance of the American Thyroid Association thyroid nodule risk stratification system (ATA-RSS) and American College of Radiology Thyroid Imagi...

S. El-Kaissi, E. Vens, Safieeldin Ghazala et al. · 0 citations
Review Open access Sep 2026

Clinicopathological Correlation of Core-Needle Biopsy in Thyroid Nodule Assessment: Insights from a Tertiary Care Center

Abstract Background: Fine-needle aspiration cytology (FNAC) is the mainstay for thyroid nodule assessment, boasting excellent specificity and cost-effectiveness. However, its diagnostic limitations often yield nondiagnostic or indeterminate results, especially in complex thyroid cases. Core-needle biopsy (CNB) has emer...

Neha Nigam, Rishabh Sahai, Anil Singh et al. · 0 citations
Open access Oct 2026

Validation of ACR TI-RADS for Predicting Cytological Outcomes in Thyroid Nodules: A Large FNA Cohort Study.

PURPOSE To evaluate the diagnostic performance of ACR TI-RADS for predicting malignant cytology in thyroid nodules undergoing fine-needle aspiration (FNA) in a large tertiary centre. METHODS A retrospective analysis was performed of 3368 thyroid nodules undergoing ultrasound-guided FNA. Nodules were classified accord...

I. Lavender, D. Nandurkar · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.